Switch to
View more

Lotus Eye Hospital and Institute Ltd

LOTUSEYE
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹110 cr, stock is ranked 2,012
High RiskStock is 3.05x as volatile as Nifty
53.150.15 (+0.28%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹110 cr, stock is ranked 2,012
High RiskStock is 3.05x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
36.97
PB RatioPB Ratio
2.10
Dividend YieldDiv. Yield
0.94%
Sector PESector PE
32.89
Sector PBSector PB
4.57
Sector Div YldSctr Div Yld
0.97%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Lotus Eye Hospital and Institute Limited is engaged in the provision of healthcare services. The Company is engaged in the field of ophthalmology (eye) and its related operation.

Investor PresentationView older 

Jul 3, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201920202021202239.1141.4833.2039.800.711.051.572.99
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Reply to Clarification Sought- Financial Results 
Announced OnJun 15, 2022

LOTUSEYE : The Exchange had sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed. | Download

LOTUSEYE : The Exchange had sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed. | Download

Clarification- Financial Results 
Announced OnJun 15, 2022
LOTUSEYE : The Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
LOTUSEYE : The Exchange has sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.
Cash Dividend 
Ex. DateSep 8, 2021

Final • Div/Share: ₹ 0.5

See all events